Donald T. Gardner III Sells 1,257 Shares of Kewaunee Scientific Co. (NASDAQ:KEQU) Stock

Kewaunee Scientific Co. (NASDAQ:KEQU - Get Free Report) CFO Donald T. Gardner III sold 1,257 shares of the firm's stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $59.26, for a total value of $74,489.82. Following the sale, the chief financial officer now directly owns 21,358 shares in the company, valued at approximately $1,265,675.08. This represents a 5.56 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Kewaunee Scientific Price Performance

Shares of KEQU traded down $2.53 during midday trading on Monday, hitting $55.20. 15,577 shares of the company traded hands, compared to its average volume of 30,768. The stock has a market cap of $158.53 million, a price-to-earnings ratio of 8.75 and a beta of 0.72. The firm has a 50 day moving average of $48.78 and a 200-day moving average of $45.11. The company has a debt-to-equity ratio of 0.48, a quick ratio of 2.00 and a current ratio of 2.53. Kewaunee Scientific Co. has a 52 week low of $27.00 and a 52 week high of $67.20.

Hedge Funds Weigh In On Kewaunee Scientific

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in KEQU. JPMorgan Chase & Co. raised its holdings in shares of Kewaunee Scientific by 18,000.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company's stock worth $30,000 after acquiring an additional 900 shares in the last quarter. Barclays PLC bought a new stake in Kewaunee Scientific in the third quarter worth $121,000. Heron Bay Capital Management purchased a new stake in Kewaunee Scientific during the second quarter valued at $252,000. State Street Corp bought a new position in Kewaunee Scientific during the third quarter valued at $266,000. Finally, Ritholtz Wealth Management grew its stake in shares of Kewaunee Scientific by 24.6% in the 3rd quarter. Ritholtz Wealth Management now owns 10,913 shares of the technology company's stock worth $363,000 after buying an additional 2,156 shares in the last quarter. 32.69% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Separately, StockNews.com upgraded shares of Kewaunee Scientific from a "hold" rating to a "buy" rating in a research report on Wednesday, December 18th.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.